AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Highlights
Accent Group secures rights to launch and manage Sports Direct in the ANZ region under a long-term partnership.
DroneShield advances on a multi-contract win with a military end customer in the Asia-Pacific region.
EBR Systems gains momentum following FDA approval for its lead-less cardiac resynchronisation system.
Accent Group operates within the footwear and apparel retail sector. Its shares are showing strength after the company disclosed a long-term arrangement to operate Sports Direct across Australia and New Zealand. The agreement includes online operations and outlines a large-scale rollout of physical stores over the coming years.
Management noted that the expansion is a result of strategic collaboration with Frasers Group, a global sporting goods leader. The plan begins with a foundation number of stores and projects wider regional coverage over time. The development aligns with Accent’s approach to bring global brands under its umbrella in the local market.
DroneShield Ltd (ASX:DRO) secures military contracts
DroneShield operates in the defense technology sector, focusing on counter-drone systems. Its shares are tracking higher following the announcement of multiple contract wins with a total order value that reflects growing demand from military entities in the Asia-Pacific.
These contracts were arranged through an in-country reseller and involve deployment to a military client. The rise in order volume coincides with broader sector tailwinds, particularly in defense and surveillance technology. The company’s year-to-date performance has received attention, as increased procurement activities follow a previously quieter phase during geopolitical transitions.
EBR Systems Inc (ASX:EBR) achieves FDA approval for heart device
EBR Systems is positioned in the medical technology sector, and its shares are advancing after receiving regulatory clearance for its WiSE CRT System in the United States. This development marks the introduction of a novel solution for delivering cardiac resynchronisation therapy without the use of leads.
This lead-less technology is the first of its kind and enables clinicians to deliver therapy to the heart’s left ventricle more efficiently. The company has identified a sizeable market for this device across several categories, including high-risk patients and those with prior device complications. The initial rollout is expected to focus on specific segments within the cardiac treatment field, with expansion based on future evaluations.
Titomic Ltd (ASX:TTT) partners with aerospace giant for manufacturing innovation
Titomic operates in the additive manufacturing space, specialising in cold spray technology. The share price climbed following the announcement of a collaborative project with aerospace and defense company Northrop Grumman.
The joint effort focuses on the production of high-performance pressure vessels, aimed at advancing manufacturing efficiency and product durability. The collaboration highlights Titomic’s technical capabilities in cold spray systems and its alignment with global aerospace requirements. This step supports its broader move toward integrated solutions in the defense sector, while underlining the strategic nature of its recent business engagements.
ASX Consumer Stocks like Accent Group (ASX:AX1) are drawing market attention through international partnerships and brand expansion strategies. These developments showcase how retail, defense, medical, and manufacturing entities continue to shape trading activity on the Australian Securities Exchange.
